Peter C. Johnson, M.D.

Peter C. Johnson, M.D., is the president and CEO of Scintellix, LLC, a biomedical technology consulting company in Raleigh, NC. He was educated at the University of Notre Dame and the SUNY Upstate Medical University. Dr. Johnson completed general surgery and plastic surgery residencies at Case-Western Reserve University and the University of Pittsburgh, respectively. He took a postdoctoral fellowship in thrombosis biology at Harvard University. Dr. Johnson practiced reconstructive surgery for 10 years on the University of Pittsburgh faculty where he founded and was the first president of the Pittsburgh Tissue Engineering Initiative, after which he cofounded and was CEO of TissueInformatics, Inc. Prior to founding Scintellix, Dr. Johnson served as CMO, EVP of life sciences and CBO of Icoria, Inc. He is a past president of the Plastic Surgery Research Council, the Pennsylvania Biotechnology Association, the Tissue Engineering Society, International, and is presently the co-editor in chief of Tissue Engineering. Dr. Johnson serves on the board of trustees of the Pittsburgh Tissue Engineering Initiative, Microscience Group, the University of North Carolina Medical Foundation, and the Advanced Regenerative Tissue Engineering Center (ARTEC) in Toronto, ON. He is the national chair of the University of North Carolina Medical Excellence Fund.

About Scintellix, LLC

Scintellix, LLC applies decision analysis methodologies to support the resolution of complex problems in personal and corporate development. It is located in Raleigh, NC.

GEN and Scintellix have formed a partnership to explore the hidden meaning found in biological imagery. The MicroArray Contest is the first installment of the partnership.